Fortis Malar Hospitals Ltd vs Krsnaa Diagnostics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Fortis Malar Hospitals Ltd is ₹ 40.21 as of 23 Oct 15:30 . The P/E Ratio of Fortis Malar Hospitals Ltd changed from 1.9 on March 2024 to 18.9 on March 2026 . This represents a CAGR of 115.06% over 3 yearsThe P/E Ratio of Krsnaa Diagnostics Ltd changed from 22.3 on March 2022 to 16.7 on March 2026 . This represents a CAGR of -5.62% over 5 years The Market Cap of Fortis Malar Hospitals Ltd changed from ₹ 103.92 crore on March 2021 to ₹ 78.13 crore on March 2026 . This represents a CAGR of -4.64% over 6 yearsThe Market Cap of Krsnaa Diagnostics Ltd changed from ₹ 1524 crore on March 2022 to ₹ 1690 crore on March 2026 . This represents a CAGR of 2.09% over 5 years The revenue of Fortis Malar Hospitals Ltd for the Jun '26 is ₹ 0.54 crore as compare to the Mar '26 revenue of ₹ 0.66 crore. This represent the decline of -18.18% The revenue of Krsnaa Diagnostics Ltd for the Jun '26 is ₹ 242.78 crore as compare to the Mar '26 revenue of ₹ 224.1 crore. This represent the growth of 8.34% The ebitda of Fortis Malar Hospitals Ltd for the Jun '26 is ₹ 0.2 crore as compare to the Mar '26 ebitda of ₹ 0.11 crore. This represent the growth of 81.82% The ebitda of Krsnaa Diagnostics Ltd for the Jun '26 is ₹ 65.23 crore as compare to the Mar '26 ebitda of ₹ 86.37 crore. This represent the decline of -24.48% The net profit of Fortis Malar Hospitals Ltd changed from ₹ -0.06 crore to ₹ 0.15 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Krsnaa Diagnostics Ltd changed from ₹ 17.92 crore to ₹ 16.55 crore over 9 quarters. This represents a CAGR of -3.47% The Dividend Payout of Fortis Malar Hospitals Ltd changed from 168.63 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Krsnaa Diagnostics Ltd changed from 11.1 % on March 2022 to 6.32 % on March 2026 . This represents a CAGR of -10.65% over 5 years .

About Fortis Malar Hospitals Ltd

Fortis Malar Hospital Limited, formerly known as Malar Hospital Limited was established on April 12, 1989 to set up, manage and operate a multi-specialty hospital.
Company is a subsidiary of Fortis Hospitals Limited and Fortis Healthcare Limited is the Intermediate Holding Company.
Later, the Company changed its name to 'Fortis Malar Hospital Limited' on December 21, 2010.
The Hospital building was owned by a fellow subsidiary, Fortis Health Management Limited (FHML) in early 2008. The hospital founded in 1989, has established itself as one of the largest corporate hospitals in Chennai, providing quality super specialty and multi-speciality healthcare services.
With a total bed-strength of 160, including 40 ICU/CCU/RTU beds, the hospital focuses on providing comprehensive medical care in the areas of Cardiology and Cardiac Surgery, Neuro Surgery, Gynaecology, Orthopedics, Gastroenterology, Neurology, Pediatrics, Diabetics, Nephrology and Internal Medicine All the above departments are fully became operational under phase I of the project.

About Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited' at Pune, Maharashtra dated December 22, 2010.
The Company name was changed to Krsnaa Diagnostics Private Limited', pursuant to a fresh Certificate of Incorporation issued by the RoC on January 29, 2015.
Thereafter, the status got converted into a Public Company and the name was changed to Krsnaa Diagnostics Limited pursuant to a fresh Certificate of Incorporation issued by the RoC on 06 May, 2021. The Company is primarily engaged in providing diagnostic services centres all over India.
The Company is providing Radiology and Pathology services for X-ray, CT Scan, MRI, Mammography, Bone Densitometry, Ultrasound, Colout Doppler, Tele-Reporting services, all type of blood and urine investigation and other related diagnostic services.

FAQs for the comparison of Fortis Malar Hospitals Ltd and Krsnaa Diagnostics Ltd

Which company has a larger market capitalization, Fortis Malar Hospitals Ltd or Krsnaa Diagnostics Ltd?

Market cap of Fortis Malar Hospitals Ltd is 75 Cr while Market cap of Krsnaa Diagnostics Ltd is 1,614 Cr

What are the key factors driving the stock performance of Fortis Malar Hospitals Ltd and Krsnaa Diagnostics Ltd?

The stock performance of Fortis Malar Hospitals Ltd and Krsnaa Diagnostics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fortis Malar Hospitals Ltd and Krsnaa Diagnostics Ltd?

As of October 25, 2026, the Fortis Malar Hospitals Ltd stock price is INR ₹40.21. On the other hand, Krsnaa Diagnostics Ltd stock price is INR ₹497.75.

How do dividend payouts of Fortis Malar Hospitals Ltd and Krsnaa Diagnostics Ltd compare?

To compare the dividend payouts of Fortis Malar Hospitals Ltd and Krsnaa Diagnostics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.